Holen Sie sich die Stockscreener-App
5.745
3.79%
0.205
Schlusskurs vom Vortag:
$5.54
Offen:
$5.53
24-Stunden-Volumen:
1.32M
Relative Volume:
0.32
Marktkapitalisierung:
$772.45M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-217.44M
KGV:
-2.6475
EPS:
-2.17
Netto-Cashflow:
$-205.20M
1W Leistung:
+3.42%
1M Leistung:
+77.47%
6M Leistung:
+222.13%
1J Leistung:
+66.67%
1-Tages-Spanne:
$5.51
$5.81
1-Wochen-Bereich:
$4.87
$5.81
52-Wochen-Spanne:
$1.11
$5.81
Prime Medicine Inc Stock (PRME) Company Profile
Firmenname
Prime Medicine Inc
Sektor
Branche
Telefon
617-465-0013
Adresse
60 FIRST ST., CAMBRIDGE
Vergleichen Sie PRME mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRME
Prime Medicine Inc
|
5.74 | 987.64M | 0 | -217.44M | -205.20M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
404.37 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
609.00 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
459.88 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
770.12 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
342.98 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Prime Medicine Inc Stock (PRME) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-27 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-05-20 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-05-20 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-12-10 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-16 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-04-22 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-04-08 | Eingeleitet | TD Cowen | Buy |
| 2024-04-03 | Eingeleitet | Wedbush | Outperform |
| 2024-01-16 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-08 | Eingeleitet | Citigroup | Neutral |
| 2023-10-09 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-07-31 | Eingeleitet | Guggenheim | Buy |
| 2023-04-18 | Eingeleitet | Stifel | Buy |
| 2022-11-14 | Eingeleitet | Goldman | Neutral |
| 2022-11-14 | Eingeleitet | JP Morgan | Overweight |
| 2022-11-14 | Eingeleitet | Jefferies | Buy |
| 2022-11-14 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Prime Medicine Inc Aktie (PRME) Neueste Nachrichten
Prime Medicine (NASDAQ:PRME) Hits New 1-Year HighTime to Buy? - MarketBeat
Prime Medicine (NASDAQ:PRME) Shares Up 3.9%Here's Why - MarketBeat
Short interest data insights for Prime Medicine Inc.Market Performance Recap & Weekly Return Optimization Alerts - newser.com
What earnings revisions data tells us about Prime Medicine Inc.Take Profit & Real-Time Chart Pattern Alerts - newser.com
Septerna appoints Keith Gottesdiener to board of directors - Investing.com India
Former Prime Medicine CEO and 20+ Drug Approval Leader Keith Gottesdiener Joins Septerna's Board - Stock Titan
Is Prime Medicine Inc. stock a buy on dips2025 Volatility Report & Real-Time Chart Pattern Alerts - newser.com
Is Prime Medicine Inc. stock entering bullish territoryTrade Volume Summary & High Win Rate Trade Alerts - newser.com
Using flow based indicators on Prime Medicine Inc.Quarterly Trade Review & Safe Capital Investment Plans - newser.com
Prime Medicine, Inc. Hits New 52-Week High of $5.20 - Markets Mojo
Prime Medicine (NASDAQ:PRME) Stock Price Down 5.6%What's Next? - MarketBeat
Prime Medicine (NYSE:PRME) Stock Price Down 5.1%What's Next? - MarketBeat
Goldman Sachs Group Inc. Lowers Stock Holdings in Prime Medicine, Inc. $PRME - MarketBeat
Prime Medicine Stock Soars 8.02%, Hits Intraday High of $5.43 - Markets Mojo
Prime Medicine, Inc. Hits New 52-Week High of $5.63 - Markets Mojo
Prime Medicine (NASDAQ:PRME) Shares Gap DownTime to Sell? - MarketBeat
Prime Medicine, Inc. $PRME Shares Purchased by Palumbo Wealth Management LLC - MarketBeat
Prime Medicine Unveils New Prime Editing Advancements - MSN
Prime Medicine, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Prime Medicine (NASDAQ:PRME) Hits New 12-Month HighWhat's Next? - MarketBeat
Prime Medicine Momentum Amid Pipeline Progress: Why I Choose To 'Hold' For Now (PRME) - Seeking Alpha
What machine learning models say about Prime Medicine Inc.2025 Major Catalysts & High Accuracy Trade Alerts - newser.com
Stock Traders Buy Large Volume of Call Options on Prime Medicine (NYSE:PRME) - MarketBeat
Prime Medicine (NASDAQ:PRME) Reaches New 52-Week HighHere's Why - MarketBeat
Prime Medicine (NYSE:PRME) Trading 5.4% HigherShould You Buy? - MarketBeat
Prime Medicine (NYSE:PRME) Shares Gap UpStill a Buy? - MarketBeat
Tech Rally: Should I trade or invest in Prime Medicine IncBond Market & Stepwise Swing Trade Plans - خودرو بانک
Prime Medicine (PRME): Evaluating Valuation After Recent LNP Innovations Spotlighted at Cell & Gene Therapy Conference - Yahoo Finance
Prime Medicine (NASDAQ:PRME) Trading 12.7% HigherShould You Buy? - MarketBeat
VIX Spike: Why is Prime Medicine Inc. stock going upWeekly Profit Summary & Community Trade Idea Sharing Platform - خودرو بانک
Meme Stocks: Is Prime Medicine Inc. backed by strong institutional buyingEarnings Summary Report & AI Enhanced Trading Signals - خودرو بانک
Panic Selling: Can Prime Medicine Inc. reach resistance levels soonPortfolio Gains Summary & High Accuracy Buy Signal Tips - خودرو بانک
Prime Medicine (NASDAQ:PRME) Shares Gap UpShould You Buy? - MarketBeat
S P Trends: Is Prime Medicine Inc. stock a smart retirement pick2025 Key Lessons & Real-Time Stock Price Movement Reports - khodrobank.com
Will Prime Medicine Inc stock hit new highs in YEARAnalyst Downgrade & Growth Oriented Trade Recommendations - khodrobank.com
Will Prime Medicine's (PRME) Innovation Messaging at CGTI Drive Lasting Competitive Advantage? - Yahoo Finance
Quarterly Earnings: What is Prime Medicine Inc.’s market position2025 Big Picture & High Accuracy Swing Entry Alerts - خودرو بانک
Prime Medicine, Inc. (NYSE:PRME) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Market Outlook: Is Prime Medicine Inc. forming higher highs and higher lowsQuarterly Growth Report & Breakout Confirmation Alerts - خودرو بانک
Fed Watch: What is the target price for Prime Medicine Inc stockTrade Exit Summary & Daily Price Action Insights - خودرو بانک
Why Cathie Wood is Loading Up on These 2 Growth Stocks (And Should You?) - yahoo.com
Merger Talk: What is Prime Medicine Inc.’s market position2025 Risk Factors & Verified Short-Term Plans - khodrobank.com
Stop Loss: Why is Prime Medicine Inc. stock going upWeekly Trade Report & Fast Gain Swing Trade Alerts - khodrobank.com
What is Prime Medicine Inc. s revenue forecastQuarterly Trade Summary & Expert Verified Movement Alerts - خودرو بانک
Head-To-Head Analysis: Prime Medicine (NYSE:PRME) and Big Cypress Acquisition (OTCMKTS:BCYP) - Defense World
What the charts say about Prime Medicine Inc. todayStock Surge & Low Drawdown Momentum Ideas - newser.com
Comparing Prime Medicine (NASDAQ:PRME) & Vor Biopharma (NASDAQ:VOR) - Defense World
Citi Downgrades Prime Medicine (PRME) to Neutral, Cuts PT to $1.50 Due to Market Uncertainty - MSN
Is Prime Medicine Inc. backed by strong institutional buyingStop Loss & Free High Accuracy Swing Entry Alerts - Lancaster City Council
Prime Medicine Inc. Breaks Losing Streak — Is the Trend ReversingJuly 2025 Institutional & Smart Allocation Stock Tips - beatles.ru
Prime Medicine (NASDAQ:PRME) Stock Price Down 3.7% After Analyst Downgrade - MarketBeat
Finanzdaten der Prime Medicine Inc-Aktie (PRME)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):